These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 308931)

  • 1. The effect of passive immunization against tetanus toxoid in man.
    Plassara M; Mandalenaki C; Papathanassiou E; Vrachnou E; Athanassiades P
    Immunology; 1978 Sep; 35(3):567-70. PubMed ID: 308931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
    Stevens RH; Saxon A
    J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid.
    Ponzio NM; Speirs RS
    Immunology; 1975 Feb; 28(2):243-51. PubMed ID: 1079015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody potential of human peripheral blood lymphocytes differentially expressing surface membrane IgM.
    Thiele CJ; Stevens RH
    J Immunol; 1980 Apr; 124(4):1898-904. PubMed ID: 6767777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined active-passive immunization against tetanus in man.
    Mahoney LJ; Aprile MA; Moloney PJ
    Can Med Assoc J; 1967 May; 96(21):1401-4. PubMed ID: 6026992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T-cell kinetics and course of humoral immune response following subcutaneous immunization with tetanus toxoid fluid vaccine].
    Thilo W; Seeger E; Kraskina NA; Jentsch P; Fritze S; Beinlich R; Fischer R; Sowa W
    Zentralbl Chir; 1983; 108(14):865-74. PubMed ID: 6605009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral lymphocytes changes in the anamnestic response to tetanus toxoid challenge.
    Chollet P; Chassagne J; Philippe P; Vuillaume C; Maublant J; Gauvin H; Rey M; Plagne R
    Clin Exp Immunol; 1979 Jul; 37(1):152-61. PubMed ID: 487652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The foetal immune response to maternal tetanus toxoid immunization.
    Dastur FD; Shastry P; Iyer E; Awatramani V; Raut S; Mehta SD; Irani SF
    J Assoc Physicians India; 1993 Feb; 41(2):94-6. PubMed ID: 8335615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG.
    Janoff EN; Hardy WD; Smith PD; Wahl SM
    J Immunol; 1991 Oct; 147(7):2130-5. PubMed ID: 1918947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymus dependence of the antibody response to tetanus toxoid in mice.
    Willcox HN
    Clin Exp Immunol; 1975 Nov; 22(2):341-7. PubMed ID: 1082404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to a single tetanus toxoid booster in young women in rural south India.
    Aruldas K; Muliyil JP; Mathai E; Abraham S; Joseph A; Inbamalar U; Aruldas V
    Natl Med J India; 2001; 14(1):22-3. PubMed ID: 11242693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of surface membrane IgG on pokeweed mitogen-reactive anti-tetanus toxoid antibody-producing cells.
    Thiele CJ; Stevens RH
    J Clin Immunol; 1981 Jul; 1(3):174-80. PubMed ID: 6801082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes.
    Brenner MK; Munro AJ
    Clin Exp Immunol; 1981 Oct; 46(1):171-7. PubMed ID: 6978212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune response of horses to tetanus toxoid.
    Jansen BC; Knoetze PC
    Onderstepoort J Vet Res; 1979 Dec; 46(4):211-6. PubMed ID: 551370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective role of membrane IgG in the antigen-induced inhibition of human in vitro antibody synthesis.
    Stevens RH; Benveniste E; Pineda E
    J Immunol; 1982 Jan; 128(1):398-401. PubMed ID: 6798112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological status of maculo-anaesthetic leprosy: T and B lymphocytes and serum immunoglobulins.
    Rao SS; Rao TD; Rao PR
    Lepr India; 1982 Jul; 54(3):471-8. PubMed ID: 6983629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELISA detection of specific functional antibodies in human serum to Escherichia coli, tetanus toxoid, and diphtheria-tetanus toxoids: normal values for IgG, IgA, and IgM.
    Moen RC; Oemichen SL; Kiggens AJ; Hong R
    Diagn Immunol; 1986; 4(1):17-23. PubMed ID: 3514070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appearance of IgG and IgA antibodies in human bile after tetanus toxoid immunization.
    Hansen PG; Hennessy EJ; Blake H; Clancy RL; Kamath R; Molenaar C; Cripps AW; Jackson GD
    Clin Exp Immunol; 1989 Aug; 77(2):215-20. PubMed ID: 2776360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell development and regulation after T cell-depleted marrow transplantation.
    Wimperis JZ; Brenner MK; Prentice HG; Thompson EJ; Hoffbrand AV
    J Immunol; 1987 Apr; 138(8):2445-50. PubMed ID: 3549902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.